TFOS DEWS II definition and classification report
The goals of the TFOS DEWS II Definition and Classification Subcommittee were to create
an evidence-based definition and a contemporary classification system for dry eye disease …
an evidence-based definition and a contemporary classification system for dry eye disease …
Tfos dews ii epidemiology report
The subcommittee reviewed the prevalence, incidence, risk factors, natural history, morbidity
and questionnaires reported in epidemiological studies of dry eye disease (DED). A meta …
and questionnaires reported in epidemiological studies of dry eye disease (DED). A meta …
TFOS DEWS II diagnostic methodology report
JS Wolffsohn, R Arita, R Chalmers, A Djalilian… - The ocular …, 2017 - Elsevier
The role of the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II
Diagnostic Methodology Subcommittee was 1) to identify tests used to diagnose and monitor …
Diagnostic Methodology Subcommittee was 1) to identify tests used to diagnose and monitor …
TFOS DEWS II management and therapy report
The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …
based review of current dry eye therapies and management options. Management options …
Tfos dews ii pathophysiology report
Abstract The TFOS DEWS II Pathophysiology Subcommittee reviewed the mechanisms
involved in the initiation and perpetuation of dry eye disease. Its central mechanism is …
involved in the initiation and perpetuation of dry eye disease. Its central mechanism is …
[HTML][HTML] NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI study
J Tauber, GJ Berdy, DL Wirta, S Krösser, JL Vittitow… - Ophthalmology, 2023 - Elsevier
Objective To evaluate the efficacy and safety of NOV03 (perfluorohexyloctane) ophthalmic
drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction …
drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction …
Artificial tears: biological role of their ingredients in the management of dry eye disease
M Labetoulle, JM Benitez-del-Castillo… - International journal of …, 2022 - mdpi.com
Dry eye disease (DED) is the most common ocular surface disease, characterized by
insufficient production and/or instability of the tear film. Tear substitutes are usually the first …
insufficient production and/or instability of the tear film. Tear substitutes are usually the first …
[HTML][HTML] The pathophysiology, diagnosis, and treatment of dry eye disease
EM Messmer - Deutsches Ärzteblatt International, 2015 - ncbi.nlm.nih.gov
Background Dry eye disease (DED) is common; its prevalence around the world varies from
5% to 34%. Its putative pathogenetic mechanisms include hyperosmolarity of the tear film …
5% to 34%. Its putative pathogenetic mechanisms include hyperosmolarity of the tear film …
Meibomian gland disease: the role of gland dysfunction in dry eye disease
P Chhadva, R Goldhardt, A Galor - Ophthalmology, 2017 - Elsevier
Topic To discuss the pathology, causes, and ocular surface impact of meibomian gland
disease (MGD), as well as its relationship to dry eye. Clinical Relevance MGD is a common …
disease (MGD), as well as its relationship to dry eye. Clinical Relevance MGD is a common …
Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape
JD Sheppard, KK Nichols - Ophthalmology and Therapy, 2023 - Springer
Meibomian gland dysfunction (MGD) is highly prevalent and is the leading cause of
evaporative dry eye disease (DED). MGD is characterized by a reduction in meibum …
evaporative dry eye disease (DED). MGD is characterized by a reduction in meibum …